Detailed Information
Cited 1 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Phase 1b/2 study of GX-I7 plus pembrolizumab in patients with refractory or recurrent (R/R) metastatic triple-negative breast cancer (mTNBC): The KEYNOTE-899 Study.
- Authors
- Sohn, J[Sohn, Joohyuk]; Kim, GM[Kim, Gun Min]; Lee, KS[Lee, Keun Seok]; Kim, SB[Kim, Sung-Bae]; Kim, JH[Kim, Jee Hung]; Ahn, HK[Ahn, Hee Kyung]; Lee, J[Lee, Jieun]; Park, KH[Park, Kyong Hwa]; Kim, JH[Kim, Jee Hyun]; Lee, KE[Lee, Kyoung Eun]; Shin, EC[Shin, Eui-Cheol]; Park, SH[Park, Su-Hyung]; Yang, SH[Yang, Se Hwan]; Heo, M[Heo, MinKyu]; Woo, JW[Woo, Jung Won]; Sung, YC[Sung, Young Chul]; Im, YH[Im, Young Hyuck]
- Issue Date
- 1-Jun-2022
- Publisher
- LIPPINCOTT WILLIAMS & WILKINS
- Citation
- JOURNAL OF CLINICAL ONCOLOGY, v.40, no.16
- Indexed
- SCIE
SCOPUS
- Journal Title
- JOURNAL OF CLINICAL ONCOLOGY
- Volume
- 40
- Number
- 16
- ISSN
- 0732-183X
- Files in This Item
- There are no files associated with this item.
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Related Researcher
- LEE, JI EUN
- Samsung Advanced Institute for Health Sciences and Technology, SKKU